J. Goldman & CO LP Abb Vie Inc. Put Options Transaction History

J. Goldman & CO LP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $3.28 Million - $3.99 Million	20,000 New	20,000 $3.95 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $399,550 - $455,250	2,500 Added 14.29%	20,000 $3.64 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $2.41 Million - $2.71 Million	17,500 New	17,500 $2.71 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $2.75 Million - $3.5 Million	20,000 New	20,000 $3.06 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.